Budesonidum, Formoteroli fumaras dihydricus

Medicinal product name Symbicort Turbuhaler 320 micrograms/9 micrograms/inhalation, inhalation powder
Pharmaceutical form Inhalation powder
Strength 320 μg/9 μg/inhalation 
Information from the MAH on shortages No information on expected shortages
Availability of medicinal product
Product No.Package sizeWholesalers' stock state
10-0467-01 KZSL2N60: 1 × 60 Is available
Legal status Rx Prescription (Pr.)
KZSL2 Next lowest cost medicine
Package leaflet MS Word document 18-03-2021
Summary of product characteristics MS Word document 18-03-2021
ATC code R03AK07 Drugs for obstructive airway diseases

Medicinal products (5)

Availability of medicinal product Wholesalers Package size, content Primary packaging Maximum admissible pharmacy price (€ incl. VAT) Product No. Labelling
 Is available (according to the information provided by wholesalers)
(27 containers)
Magnum Medical, Tamro, Baltfarm "Vita-Farm", Euroaptieka N60: 1 × 60
(320 µg/9 µg/dose)
Inhaler 63.95 
KZSL2*
10-0467-01 Labelling text Labelling text Jun 29, 2017
 Not available (according to the information provided by wholesalers) currently no information on availability from any wholesaler N120: 2 × 60
(320 µg/9 µg/dose)
Inhaler    10-0467-02 Labelling text Labelling text Jun 29, 2017
 Not available (according to the information provided by wholesalers) currently no information on availability from any wholesaler N180: 3 × 60
(320 µg/9 µg/dose)
Inhaler    10-0467-03 Labelling text Labelling text Jun 29, 2017
 Not available (according to the information provided by wholesalers) currently no information on availability from any wholesaler N600: 10 × 60
(320 µg/9 µg/dose)
Inhaler    10-0467-04 Labelling text Labelling text Jun 29, 2017
 Not available (according to the information provided by wholesalers) currently no information on availability from any wholesaler N1080: 18 × 60
(320 µg/9 µg/dose)
Inhaler    10-0467-05 Labelling text Labelling text Jun 29, 2017
* Indication about medicine on the List of state reimbursed medicines is just informative. Source of the information is the National Health Service. For details please visit the NHS website.

Registration information

Marketing authorisation No. 10-0467
Date of authorisation Oct 1, 2010
MA valid until For unlimited time
Marketing authorisation holder, country AstraZeneca AB, Sweden